Letter From The Editor

Now that Thanksgiving is over, it is time for our patients to start their annual “food drive.” I don’t mean collecting food for charities: I am referring to them eating as much food as possible over the next four weeks. This is the time of year most of our patients …

When it comes to knowledge sometimes you just can’t get enough when you are interested in a topic. Over the past six months we have spent a lot of time giving you the most-up-to-date and relevant information on GLP-1 therapy that we could find. We have provided interviews with thought …

Unlike fine wine, humans don’t get better with age, especially when we are talking about AGEs (Advanced Glycation End-products). This week we continue our Homerun Slides series on these damaging compounds and how they affect each organ in the body. Our journey into the psychology of diabetes has reached the grade …

This week finishes off National Diabetes Month, and over the past few weeks I have received countless videos, emails and tweets about diabetes. I have also noticed that more and more of my patients are watching You Tube, Netflix, sports or TV on their smartphones or tablets. Last week I …

Some of you may remember the term “Schiff base” from your days in the chemistry lab, but do you have any idea what this compound has to do with diabetes? When it comes to advanced glycation end products (AGEs), a Schiff base is what contributes to the overall damage. This …

According to Webster’s, a “publisher is responsible for the selection, preparation, and distribution of information,” and usually has no involvement in the actual development of content or material. However, when the publisher has over 20 years of experience in diabetes care, you can expect a little more from them. This …

Have you ever had a patient who is a pre-school child with diabetes? Usually this means that the parents are trying to stay in control and the child wants more independence. In this issue’s Clinical Gem, we focus on the battles that everyone faces during this time and why they occur. …

This week we are headlining the break-up of the Lilly-Amylin alliance and how that might affect the anticipated sales of the hopefully soon-to-be-approved Bydureon. Most of us found it hard to believe that after all this time that Lilly would give up on the exenatide franchise but when you examine …

We try to make insulin use as simple and painless as possible for our patients, and this usually means trying to limit the number of injections a day and selecting the shortest, thinnest needle possible. Most of the time this works fine but this week’s Disaster Averted, Ask the Right …

Last week we had an item about the water consumption and glucose levels and there was a tip on how to get your patients to drink more. Now there is a study in this month’s International Journal of Obesity that confirms that drinking ice cold water increases metabolism and burns …